Cargando…

Editorial: The Role of Lipids in the Pathogenesis of Parkinson's Disease

Detalles Bibliográficos
Autores principales:	Baekelandt, Veerle, Lobbestael, Evy, Xicoy, Helena, Martens, Gerard J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105851/ https://www.ncbi.nlm.nih.gov/pubmed/32265647 http://dx.doi.org/10.3389/fnins.2020.00250

Ejemplares similares

Multiple-Hit Hypothesis in Parkinson’s Disease: LRRK2 and Inflammation
por: Cabezudo, Diego, et al.
Publicado: (2020)

The Role of Lipids in Parkinson’s Disease
por: Xicoy, Helena, et al.
Publicado: (2019)

Editorial: Protein Degradation Pathways in Parkinson's Disease and Neurodegeneration
por: Volta, Mattia, et al.
Publicado: (2020)

Regulation and targeting of enzymes mediating Parkinson's disease pathogenesis: focus on Parkinson's disease kinases, GTPases, and ATPases
por: Taymans, Jean-Marc, et al.
Publicado: (2014)

RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8A
por: Madero-Pérez, Jesús, et al.
Publicado: (2018)

Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson’s Disease
por: Xicoy, Helena, et al.
Publicado: (2020)

In silico, in vitro and cellular analysis with a kinome-wide inhibitor panel correlates cellular LRRK2 dephosphorylation to inhibitor activity on LRRK2
por: Vancraenenbroeck, Renée, et al.
Publicado: (2014)

Lipid Analysis of the 6-Hydroxydopamine-Treated SH-SY5Y Cell Model for Parkinson’s Disease
por: Xicoy, Helena, et al.
Publicado: (2019)

Shared genetic etiology between Parkinson’s disease and blood levels of specific lipids
por: Xicoy, Helena, et al.
Publicado: (2021)

The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
por: Xicoy, Helena, et al.
Publicado: (2017)

Pathogenic LRRK2 requires secondary factors to induce cellular toxicity
por: Lobbestael, Evy, et al.
Publicado: (2020)

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
por: Li, Puyu, et al.
Publicado: (2021)

Increased Levels of the Parkinson’s Disease-Associated Gene ITPKB Correlate with Higher Expression Levels of α-Synuclein, Independent of Mutation Status
por: Di Leva, Francesca, et al.
Publicado: (2023)

ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization
por: Si, Jianmin, et al.
Publicado: (2021)

Lipids as Trans-Acting Effectors for α-Synuclein in the Pathogenesis of Parkinson’s Disease
por: Ikenaka, Kensuke, et al.
Publicado: (2019)

Editorial: The Role of Stem Cells, Epigenetics and MicroRNAs in Parkinson's Disease
por: Hegarty, Shane V., et al.
Publicado: (2020)

LRRK2 Kinase Activity Is Dependent on LRRK2 GTP Binding Capacity but Independent of LRRK2 GTP Binding
por: Taymans, Jean-Marc, et al.
Publicado: (2011)

The role of the endolysosomal pathway in α-synuclein pathogenesis in Parkinson’s disease
por: Smith, Jessica K., et al.
Publicado: (2023)

Immunohistochemical detection of transgene expression in the brain using small epitope tags
por: Lobbestael, Evy, et al.
Publicado: (2010)

Role of Chaperone-Mediated Autophagy Dysfunctions in the Pathogenesis of Parkinson’s Disease
por: Sala, Gessica, et al.
Publicado: (2016)

PAK6 Phosphorylates 14-3-3γ to Regulate Steady State Phosphorylation of LRRK2
por: Civiero, Laura, et al.
Publicado: (2017)

Editorial: The role of microglia in the pathogenesis of neurodegenerative diseases
por: Qin, Qi, et al.
Publicado: (2023)

Interaction of Alpha-Synuclein With Lipids: Mitochondrial Cardiolipin as a Critical Player in the Pathogenesis of Parkinson’s Disease
por: Gilmozzi, Valentina, et al.
Publicado: (2020)

Increased P2X7 Receptor Binding Is Associated With Neuroinflammation in Acute but Not Chronic Rodent Models for Parkinson’s Disease
por: Crabbé, Melissa, et al.
Publicado: (2019)

Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease
por: Gelders, Géraldine, et al.
Publicado: (2018)

Rab32 interacts with SNX6 and affects retromer-dependent Golgi trafficking
por: Waschbüsch, Dieter, et al.
Publicado: (2019)

The Roles of Post-translational Modifications on α-Synuclein in the Pathogenesis of Parkinson’s Diseases
por: Zhang, Jiaming, et al.
Publicado: (2019)

Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson’s Disease
por: Klemann, Cornelius J. H. M., et al.
Publicado: (2017)

Proteostasis of α-Synuclein and Its Role in the Pathogenesis of Parkinson’s Disease
por: Han, Deqiang, et al.
Publicado: (2020)

Gut Inflammation in Association With Pathogenesis of Parkinson’s Disease
por: Chen, Qian-Qian, et al.
Publicado: (2019)

Parkinson’s disease-implicated kinases in the brain; insights into disease pathogenesis
por: Dzamko, Nicolas, et al.
Publicado: (2014)

Insights Into the Role of Platelet-Derived Growth Factors: Implications for Parkinson’s Disease Pathogenesis and Treatment
por: Li, Dan, et al.
Publicado: (2022)

Editorial: Integrative Approach to Parkinson's Disease
por: Kim, Seung-Nam, et al.
Publicado: (2019)

Editorial: Sleep disturbances in Parkinson's disease
por: Salsone, Maria, et al.
Publicado: (2023)

Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
por: Alecu, Irina, et al.
Publicado: (2019)

Editorial: Sound, Music, and Movement in Parkinson’s Disease
por: Bieńkiewicz, Marta M. N., et al.
Publicado: (2016)

Cross-Talk Between Mitochondria and Proteasome in Parkinson's Disease Pathogenesis
por: Branco, Diogo Martins, et al.
Publicado: (2010)

α-synuclein pathogenesis in hiPSC models of Parkinson’s disease
por: Baena-Montes, Jara M., et al.
Publicado: (2021)

Editorial: Microglial Polarization in the Pathogenesis and Therapeutics of Neurodegenerative Diseases
por: Tang, Yu
Publicado: (2018)

Editorial: Genetic and Epigenetic Mechanisms of Parkinson's Disease
por: Li, Song, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_72arrmia3511lc0u7uks8ug1l3